Sign In
Buy CET
$52.70
-0.570 (-1.07%)
At Close: Jun 03, 2026
3 Old School CEFs That Consistently Beat The Market
10:51am, Tuesday, 23'rd Dec 2025
Adams Diversified Equity Fund, Central Securities Corporation, and General American Investors Co. Inc. are longstanding equity CEFs, each outperforming the S&P 500 over the past decade while trading a
Central Securities Corporation Announces Reinvestment Price of Shares for Distribution Payable December 19, 2025
05:05pm, Wednesday, 03'rd Dec 2025
NEW YORK--(BUSINESS WIRE)--Central Securities Corporation (NYSE American: CET) announced today that the price at which Common Stock will be issued in payment of the $2.45 per share distribution payabl
BNP Paribas raises CET1 ratio target to 13% by 2027
01:22am, Thursday, 20'th Nov 2025
French bank BNP Paribas on Thursday raised its CET1 ratio target to 13% by 2027, up from 12.5% previously, based on stronger group profitability, moderate growth in risk-weighted assets of around 2% p
BNP Paribas : CET1 RATIO TARGET RAISED TO 13% BY 2027 - ECB authorisation for €1.15 billion share buyback program
01:00am, Thursday, 20'th Nov 2025
PRESS RELEASE Paris, 20th November 2025 BNP Paribas has raised its CET1 ratio target to 13% by 2027. This ambition is driven by three key factors: stronger Group profitability supporting capital gener
CET: This Solid Fund Will Soon Pay Out A Large Year-End Distribution
12:39am, Wednesday, 12'th Nov 2025
Central Securities Corporation offers a concentrated, value-oriented US equity portfolio trading at a 15.5% discount to NAV. CET's major private holding, Plymouth Rock, is likely undervalued in CET's
Central Securities Corporation Releases Report to Stockholders
04:05pm, Monday, 10'th Nov 2025
NEW YORK--(BUSINESS WIRE)--Central Securities Corporation (NYSE American: CET), a closed-end investment company, today released its Report to Stockholders for the nine months ended September 30, 2025.
Zealand Pharma conference call on November 13 at 2pm CET (8am ET) to present third quarter 2025 financial results
11:30am, Thursday, 06'th Nov 2025
Press Release – No. 15 / 2025 Zealand Pharma conference call on November 13 at 2pm CET (8am ET) to present third quarter 2025 financial results Copenhagen, Denmark, November 6, 2025 – Zealand P
Central Securities Corporation Declares Year-End Distribution
04:05pm, Tuesday, 04'th Nov 2025
NEW YORK--(BUSINESS WIRE)--Central Securities Corporation (NYSE American: CET), a closed-end investment company, today declared a distribution of $2.45 per share on its Common Stock. The dividend is p
Invitation to presentation of BioArctic's third quarter report for July - September 2025 on November 13 at 9.30 a.m. CET
04:29am, Tuesday, 04'th Nov 2025
/PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will publish the company's third quarter report for July - September 2025 on Thursday, November
Invitation to presentation of BioArctic's third quarter report for July - September 2025 on November 13 at 9.30 a.m. CET
04:25am, Tuesday, 04'th Nov 2025
/PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will publish the company's third quarter report for July - September 2025 on Thursday, November
International Petroleum Corporation to release Third Quarter 2025 Financial and Operational Results on November 4, 2025
04:00am, Thursday, 30'th Oct 2025
International Petroleum Corporation (IPC) (TSX, Nasdaq Stockholm: IPCO) will publish its financial and operating results and related management's discussion and analysis for the three and nine months
argenx Reports Third Quarter 2025 Financial Results and Provides Business Update
02:00am, Thursday, 30'th Oct 2025
$1.13 billion in third quarter global product net sales On track to submit seronegative gMG sBLA by year-end and report ADAPT-OCULUS results in 1H26 – supporting pursuit of broadest MG label of an
Webcast details for Orrön Energy's Q3 presentation
03:00am, Thursday, 23'rd Oct 2025
Orrön Energy AB (“Orrön Energy”) will publish its financial report for the third quarter 2025 on Wednesday, 5 November 2025 at 07:30 CET, followed by a webcast at 14:00 CET.
Invitation to Electrolux Group Capital Markets Update, December 4, 2025
10:17am, Wednesday, 22'nd Oct 2025
STOCKHOLM , Oct. 22, 2025 /PRNewswire/ -- Electrolux Group has the pleasure of inviting investors, financial analysts and business media representatives to its Capital Markets Update on December 4, 20
PRESS RELEASE AB SCIENCE PROVIDES INITIAL PHASE 1 DATA FOR THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA Paris, 16 October 2025, 9pm CET
